('telogen', 0.0003046784220929357)
('MIR384', 0.0003045361236692454)
('IGFBPL1', 0.00030447188328019427)
('TRPC3', 0.0003044430645746095)
('HCT-8_cell', 0.00030437786971865033)
('TRBV19', 0.0003043684872298114)
('Infigratinib', 0.0003043634620315099)
('NOMO1', 0.00030435934077675434)
('Vemurafenib', 0.0003043465568222868)
('lymphoblastic_leukemia_cell', 0.0003042776536054573)
('ESD', 0.0003041478239153687)
('embigin', 0.0003039543426006732)
('TRBV9', 0.0003039542381328707)
('MED8', 0.00030393689965875275)
('Sulfadiazine', 0.00030376006656883473)
('vitamin D2', 0.0003037225020772883)
('phototransduction', 0.0003035718933299006)
('RPS10', 0.00030354284674962556)
('Troglitazone', 0.00030350493640301086)
('ELL3', 0.00030341062717239805)
('Rivaroxaban', 0.0003031971288481655)
('lysosomal_storage_disease_pathway', 0.00030312041240527804)
('arachidonic_acid_metabolic_process', 0.00030279316996907705)
('submandibular_gland', 0.00030274417605080927)
('hypervitaminosis_D', 0.00030268215930914327)
('Methylprednisone', 0.000302432924003695)
('Noonan_syndrome_2', 0.0003023291599209383)
('interferon α2b', 0.00030231933575231533)
('type_I_interferon_production', 0.0003023012057559424)
('nitric_oxide_biosynthetic_process', 0.0003023012057559424)
('GBP4', 0.0003023012057559424)
('PRKAR2A', 0.0003023012057559424)
('methyl-prednisolone', 0.0003023012057559424)
('Interferon-α2b', 0.0003023012057559424)
('progesterone_receptor_binding', 0.0003023012057559424)
('L-6_myoblast_cell', 0.0003023012057559424)
('FLG2', 0.0003023012057559424)
('cataract_7', 0.0003023012057559424)
('FBXO17', 0.0003023012057559424)
('calmodulin_binding', 0.00030215273215676754)
('corticotropic_cell', 0.00030206963315919675)
('perineuronal_net', 0.00030204175902598813)
('SPRY4', 0.0003018526759249908)
('MTMR11', 0.000301749047511614)
('interleukin-3_receptor_activity', 0.0003016681444708352)
('CPO', 0.00030138769363767954)
('PAWR', 0.00030123505693948623)
('SYNJ2', 0.000301131680512797)
('HM13', 0.0003011239094595035)
('maraviroc', 0.0003007278905918187)
('cystic_echinococcosis', 0.00030070194851790333)
('neurogenic_arthropathy', 0.00030064707662238977)
('APC2', 0.0003005558286252819)
('DGCR5', 0.0003005125229634117)
('L-363_cell', 0.0003003929288170246)
('TTI1', 0.0003001447871581111)
('Talazoparib', 0.0003000538198814766)
('mammary_gland_morphogenesis', 0.00029996488836025456)
('RPL34', 0.0002999441163971296)
('2CdA', 0.0002998908095411604)
('siderosis', 0.00029988538076755004)
('spondyloarthropathy', 0.0002998482845459123)
('MAGED1', 0.00029980477097419077)
('Avapritinib', 0.00029967127096132407)
('CCRF-HSB-2_cell', 0.00029960500707158837)
('MLLT10', 0.00029939429974911174)
('shelterin_complex', 0.0002993461633519938)
('H1-6', 0.00029924457378579676)
('cone-rod_dystrophy_1', 0.00029916957638132945)
('ZBTB2', 0.0002991167202737278)
('CNE-2_cell', 0.00029904135724009807)
('spondylolisthesis', 0.000299003816247301)
('EPHB3', 0.00029895960254294757)
('signal_recognition_particle', 0.0002988780723130581)
('oxidoreductase_activity__acting_on_diphenols_and_related_substances_as_donors__oxygen_as_acceptor', 0.0002986855490749615)
('ependymal_epithelium', 0.00029863007366554055)
('myxedema', 0.0002984564491238677)
('human_brain_microvascular_endothelial_cell', 0.0002983749096605365)
('CISD2', 0.0002982999604325805)
('Matuzumab', 0.0002982517632251949)
('zinc_ion_binding', 0.0002981595730706834)
('MCM2', 0.00029800629694634264)
('NEFH', 0.000297996956569087)
('acute_megakaryoblastic_leukemia_cell', 0.0002978982787487223)
('NKX2-3', 0.00029776264068970927)
('Thymol', 0.0002977025561953504)
('BJAB_cell', 0.0002975566076916292)
('X-linked_severe_combined_immunodeficiency', 0.00029754179573595116)
('fibrosarcoma_cell', 0.00029724358843210386)
('decidua', 0.00029718335568218766)
('catagen', 0.00029697146869403355)
('subsynaptic_reticulum', 0.0002968499980045977)
('ZNF32', 0.0002966752708415708)
('corneocyte', 0.00029656714078576816)
('spindle_pole_body', 0.0002963791993825339)
('FOXA2', 0.00029634744192848065)
